Skip to search formSkip to main contentSkip to account menu

Recombinant EphB4-HSA Fusion Protein

Known as: sEphB4-HSA 
A recombinant fusion protein composed of the full-length extracellular domain (soluble) of human receptor tyrosine kinase ephrin type-B receptor 4… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
4640Background: EphB4, a receptor kinase expressed in most epithelial tumors, binds EphrinB2 to affect cancer cell growth… 
2020
2020
TPS274Background: The EphB4/EphrinB2 pathway is a promising therapeutic target for patients with mCRPC. EphB4 expression is… 
2018
2018
285Background: EphrinB4, a receptor kinase, is associated with stage and survival in epithelial cancers. sEphB4 is a fusion… 
2014
2014
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Introduction: EphB4, a receptor tyrosine kinase, binds to… 
2014
2014
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Triple negative breast cancer (TNBC) represents a… 
2013
2013
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Introduction: Receptor tyrosine kinase EphB4 and its… 
2012
2012
The use of albumin fusion proteins as therapeutic drug candidates is an attractive approach to design novel biopharmaceuticals…